Skip to main content
. 2020 Jan 21;2020:6760205. doi: 10.1155/2020/6760205

Table 2.

Periprocedural characteristics.

Parameter BiOSS group DES group
No ISR ISR No ISR ISR
N = 198 (%) n = 24 (%) N = 206 (%) n = 17 (%)
MV predilatation 117 (59.1) 20 (83.3) 145 (70.4) 14 (82.4)
SB predilatation 67 (33.8) 7 (29.2) 57 (27.7) 8 (47.1)∗,∗∗
Nominal stent diameter [mm] 3.34 ± 0.45 3.22 ± 0.51
Nominal stent diameter in MV [mm] 3.70 ± 0.33 3.72 ± 0.41
Nominal stent diameter in MB [mm] 3.01 ± 0.34 3.00 ± 0.38
Nominal stent length [mm] 17.44 ± 1.54 18.21 ± 2.50 20.28 ± 4.32 20.53 ± 5.62
Sirolimus eluting 88 (44.4) 14 (58.3) 148 (71.8) 7 (41.2)∗,∗∗
Paclitaxel eluting 110 (55.6) 10 (41.7) 58 (28.2) 10 (58.8)∗,∗∗
POT 81 (40.9) 2 (8.3) 152 (73.8) 1 (5.9)
FKB 65 (32.8) 6 (25) 101 (49) 9 (52.9)∗∗
stent in SB 17 (8.6) 5 (20.8) 7 (3.4) 8 (47.1)∗,∗∗

P < 0.05 No ISR vs. ISR in BiOSS or rDES groups. ∗∗P < 0.05 ISR between BiOSS and rDES groups. FKB: final kissing balloon; ISR: in-stent restenosis; MB: main branch; MV: main vessel; POT: proximal optimization technique; SB: side branch.